Evidence map›Paper›PMID 39820807›Full record

ArticleJournal of neurology2025

Respiratory failure as main presentation sign of MAPT-related disorder.

Maud Favier, Maité Formaglio, Anne Cosson, Frédéric Claudé, Anne-Laure Fauret-Amsellem, Fabienne Clot, Elsa Dionet, Matthieu Bereau, Juliette Piard

Erratum issuedAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Maud FavierCentre de Génétique Humaine, Centre Hospitalier Universitaire de Besançon, Besançon, France. maud.favier@aphp.fr.ORCID http://orcid.org/0009-0006-1011-875X
Maité FormaglioService de Neuro-Cognition, Hôpital Neurologique et Centre Mémoire Ressource Recherche (CMRR) de Lyon, Lyon, France.
Anne CossonDépartement de Neurologie, Centre Hospitalier Universitaire de Besançon, Besançon, France.
Frédéric ClaudéPneumologie, Oncologie Thoracique et Allergologie Respiratoire, Centre Hospitalier Universitaire de Besançon, Besançon Cedex, France.
Anne-Laure Fauret-AmsellemDépartement de Génétique Médicale, UF de Neurogénétique Moléculaire et Cellulaire, AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.
Fabienne ClotDépartement de Génétique Médicale, UF de Neurogénétique Moléculaire et Cellulaire, AP-HP Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.
Elsa DionetService de Neurologie, Centre Mémoire Ressource Recherche (CMRR), Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France.
Matthieu BereauDépartement de Neurologie, Centre Hospitalier Universitaire de Besançon, Besançon, France.
Juliette PiardCentre de Génétique Humaine, Centre Hospitalier Universitaire de Besançon, Besançon, France. jpiard@chu-besancon.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe MAPT gene encodes Tau, a protein mainly expressed by neurons. Tau protein plays an important role in cerebral microtubule polymerization and stabilization, in axonal transport and synaptic plasticity. Heterozygous pathogenic variation in MAPT are involved in a spectrum of autosomal dominant neurodegenerative diseases known as taupathies, including Alzheimer's disease, Pick's disease, fronto-temporal dementia, cortico-basal degeneration and progressive supranuclear palsy. Taupathies are characterized by the constant presence of neuronal and/or glial aberrant Tau inclusions leading to atrophy and subsequent neuronal loss resulting in central nervous system degeneration. We report here two unrelated families in which segregates a MAPT-related neurodegenerative disorder marked by respiratory failure in the foreground.

resultsNine individuals from two unrelated families were affected by a neurodegenerative disorder. Respiratory features were progressively worsening dyspnea-orthopnea with episodes of acute respiratory decompensation leading to hypercapnic coma or sudden death. A diaphragmatic paralysis was shown in three cases. Associated neurological signs were gait disturbances, bulbar signs including swallowing disorders and dysarthria, pyramidal signs, cognitive and behavioral disorders. ENMG inconstantly found signs of mild denervation. Post-mortem brain immuno-histochemical analysis in one patient revealed unusual composite neuronal Tau inclusions, significant neuronal loss and reactive gliosis, in cortical and subcortical regions, cranial nerves and anterior horn of spinal cord. The heterozygous missense variant c.2041C > T, p. (Pro681Ser) in MAPT was identified in both families by gene panel or exome sequencing. DISCUSSION: In the literature, four additional related patients carrying the same MAPT variant, in heterozygous state, also presented rapidly progressive respiratory failure and unusual composite neuronal Tau inclusions in anterior horn of spinal cord.

conclusionOur observation allows to extend the phenotypic spectrum associated with MAPT variants describing a rapidly progressive respiratory failure, with episodes of exacerbations and premature death.

Indexed as

Respiratory InsufficiencyTauopathiestau ProteinsAdultAgedBrainFemaleHumansMaleMiddle AgedPedigreeMAPT protein, humantau ProteinsMAPTMotor neurone diseaseNeurodegenerative diseaseRespiratory failureTetrapyramidal syndrome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.